Suvretta Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,363,675
| Closed | -$8.95M | – | 109 |
|
|
2024
Q1 | $8.95M | Sell |
1,363,675
-4,473,451
| -77% | -$29.3M | 0.33% | 50 |
|
|
2023
Q4 | $37.9M | Sell |
5,837,126
-204,784
| -3% | -$1.33M | 1.71% | 20 |
|
|
2023
Q3 | $30.4M | Buy |
6,041,910
+480,075
| +9% | +$2.41M | 1.64% | 19 |
|
|
2023
Q2 | $48.7M | Buy |
5,561,835
+2,113,560
| +61% | +$18.5M | 2.6% | 10 |
|
|
2023
Q1 | $40.8M | Hold |
3,448,275
| – | – | 1.72% | 20 |
|
|
2022
Q4 | $35.1M | Buy |
+3,448,275
| New | +$35.1M | 1.47% | 29 |
|
|
2022
Q3 | – | Sell |
-1,238,800
| Closed | -$3.07M | – | 87 |
|
|
2022
Q2 | $3.07M | Hold |
1,238,800
| – | – | 0.12% | 71 |
|
|
2022
Q1 | $3.68M | Hold |
1,238,800
| – | – | 0.11% | 67 |
|
|
2021
Q4 | $8.76M | Buy |
1,238,800
+113,064
| +10% | +$799K | 0.17% | 64 |
|
|
2021
Q3 | $11.7M | Buy |
1,125,736
+600
| +0.1% | +$6.25K | 0.2% | 61 |
|
|
2021
Q2 | $13.8M | Hold |
1,125,136
| – | – | 0.21% | 71 |
|
|
2021
Q1 | $24.8M | Buy |
+1,125,136
| New | +$24.8M | 0.37% | 52 |
|